The most ambitious risk score project is the IPSET-thrombosis [10], which has been validated retrospectively but not prospectively, and contains age >60, thrombosis history, cardiovascular risk and JAK2 positivity. This evidence concerns the gene JAK2 and Venous thrombosis.